25 XP   0   0   10

Sequent Scientific Limited
Buy, Hold or Sell?

Let's analyse Sequent together

PenkeI guess you are interested in Sequent Scientific Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sequent Scientific Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sequent Scientific Limited

I send you an email if I find something interesting about Sequent Scientific Limited.

Quick analysis of Sequent (30 sec.)










What can you expect buying and holding a share of Sequent? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
INR29.95
Expected worth in 1 year
INR31.65
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
INR1.70
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
INR115.50
Expected price per share
INR108.10 - INR156.00
How sure are you?
50%

1. Valuation of Sequent (5 min.)




Live pricePrice per Share (EOD)

INR115.50

Intrinsic Value Per Share

INR-28.88 - INR9.08

Total Value Per Share

INR1.08 - INR39.03

2. Growth of Sequent (5 min.)




Is Sequent growing?

Current yearPrevious yearGrowGrow %
How rich?$89.9m$88.8m$1m1.2%

How much money is Sequent making?

Current yearPrevious yearGrowGrow %
Making money-$14.5m$4.9m-$19.4m-133.8%
Net Profit Margin-8.5%2.9%--

How much money comes from the company's main activities?

3. Financial Health of Sequent (5 min.)




What can you expect buying and holding a share of Sequent? (5 min.)

Welcome investor! Sequent's management wants to use your money to grow the business. In return you get a share of Sequent.

What can you expect buying and holding a share of Sequent?

First you should know what it really means to hold a share of Sequent. And how you can make/lose money.

Speculation

The Price per Share of Sequent is INR115.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sequent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sequent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR29.95. Based on the TTM, the Book Value Change Per Share is INR0.42 per quarter. Based on the YOY, the Book Value Change Per Share is INR-1.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sequent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.06-0.1%-0.06-0.1%0.020.0%0.010.0%0.020.0%
Usd Book Value Change Per Share0.010.0%0.010.0%-0.020.0%0.010.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%-0.010.0%0.010.0%0.030.0%
Usd Price Per Share0.87-0.87-1.61-1.43-1.14-
Price to Earnings Ratio-14.99--14.99-81.33-38.77--23.36-
Price-to-Total Gains Ratio171.23-171.23--121.53-1,057.15-664.63-
Price to Book Ratio2.42-2.42-4.53-3.91-2.97-
Price-to-Total Gains Ratio171.23-171.23--121.53-1,057.15-664.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.386
Number of shares721
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (721 shares)3.676.72
Gains per Year (721 shares)14.6726.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10155101717
202920193544
304435295271
405950386998
5073654887125
60888057104152
701039567122179
8011711076139206
9013212586156233
10014714095174260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%8.09.00.047.1%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%11.06.00.064.7%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%8.00.02.080.0%13.00.04.076.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%12.05.00.070.6%

Fundamentals of Sequent

About Sequent Scientific Limited

Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Fundamental data was last updated by Penke on 2024-03-12 23:07:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sequent Scientific Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sequent earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -8.5% means that ₹-0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sequent Scientific Limited:

  • The MRQ is -8.5%. The company is making a loss. -1
  • The TTM is -8.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-8.5%TTM-8.5%0.0%
TTM-8.5%YOY2.9%-11.4%
TTM-8.5%5Y2.4%-11.0%
5Y2.4%10Y3.0%-0.6%
1.1.2. Return on Assets

Shows how efficient Sequent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.9% Return on Assets means that Sequent generated ₹-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sequent Scientific Limited:

  • The MRQ is -7.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.9%TTM-7.9%0.0%
TTM-7.9%YOY2.8%-10.8%
TTM-7.9%5Y2.0%-9.9%
5Y2.0%10Y2.0%0.0%
1.1.3. Return on Equity

Shows how efficient Sequent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.3% Return on Equity means Sequent generated ₹-0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sequent Scientific Limited:

  • The MRQ is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-17.3%0.0%
TTM-17.3%YOY5.9%-23.3%
TTM-17.3%5Y3.6%-20.9%
5Y3.6%10Y-12.7%+16.3%

1.2. Operating Efficiency of Sequent Scientific Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sequent is operating .

  • Measures how much profit Sequent makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -4.0% means the company generated ₹-0.04  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sequent Scientific Limited:

  • The MRQ is -4.0%. The company is operating very inefficient. -2
  • The TTM is -4.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.0%TTM-4.0%0.0%
TTM-4.0%YOY4.8%-8.8%
TTM-4.0%5Y6.6%-10.6%
5Y6.6%10Y7.5%-0.9%
1.2.2. Operating Ratio

Measures how efficient Sequent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are ₹1.02 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Sequent Scientific Limited:

  • The MRQ is 1.019. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.019. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.019TTM1.0190.000
TTM1.019YOY0.952+0.067
TTM1.0195Y0.923+0.096
5Y0.92310Y0.952-0.029

1.3. Liquidity of Sequent Scientific Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sequent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.50 means the company has ₹1.50 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Sequent Scientific Limited:

  • The MRQ is 1.501. The company is able to pay all its short-term debts. +1
  • The TTM is 1.501. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.501TTM1.5010.000
TTM1.501YOY1.536-0.035
TTM1.5015Y1.494+0.008
5Y1.49410Y1.294+0.200
1.3.2. Quick Ratio

Measures if Sequent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.73 means the company can pay off ₹0.73 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sequent Scientific Limited:

  • The MRQ is 0.732. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.732. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.732TTM0.7320.000
TTM0.732YOY0.762-0.029
TTM0.7325Y0.861-0.129
5Y0.86110Y0.776+0.085

1.4. Solvency of Sequent Scientific Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sequent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sequent to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Sequent assets are financed with 51.0% credit (debt) and the remaining percentage (100% - 51.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sequent Scientific Limited:

  • The MRQ is 0.510. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.510. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.510TTM0.5100.000
TTM0.510YOY0.486+0.024
TTM0.5105Y0.476+0.034
5Y0.47610Y0.535-0.058
1.4.2. Debt to Equity Ratio

Measures if Sequent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 111.6% means that company has ₹1.12 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sequent Scientific Limited:

  • The MRQ is 1.116. The company is able to pay all its debts with equity. +1
  • The TTM is 1.116. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.116TTM1.1160.000
TTM1.116YOY1.013+0.104
TTM1.1165Y0.973+0.143
5Y0.97310Y2.462-1.489

2. Market Valuation of Sequent Scientific Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Sequent generates.

  • Above 15 is considered overpriced but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -14.99 means the investor is paying ₹-14.99 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sequent Scientific Limited:

  • The EOD is -23.843. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.987. Based on the earnings, the company is expensive. -2
  • The TTM is -14.987. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23.843MRQ-14.987-8.856
MRQ-14.987TTM-14.9870.000
TTM-14.987YOY81.327-96.314
TTM-14.9875Y38.773-53.760
5Y38.77310Y-23.363+62.135
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sequent Scientific Limited:

  • The EOD is -41.643. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -26.176. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -26.176. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-41.643MRQ-26.176-15.467
MRQ-26.176TTM-26.1760.000
TTM-26.176YOY-1,794.976+1,768.801
TTM-26.1765Y-335.667+309.491
5Y-335.66710Y-283.257-52.409
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sequent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.42 means the investor is paying ₹2.42 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Sequent Scientific Limited:

  • The EOD is 3.856. Based on the equity, the company is fair priced.
  • The MRQ is 2.424. Based on the equity, the company is underpriced. +1
  • The TTM is 2.424. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.856MRQ2.424+1.432
MRQ2.424TTM2.4240.000
TTM2.424YOY4.531-2.107
TTM2.4245Y3.911-1.488
5Y3.91110Y2.971+0.940
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sequent Scientific Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4240.4240%-1.593+476%0.502-16%2.596-84%
Book Value Per Share--29.95429.9540%29.530+1%30.425-2%26.747+12%
Current Ratio--1.5011.5010%1.536-2%1.494+1%1.294+16%
Debt To Asset Ratio--0.5100.5100%0.486+5%0.476+7%0.535-5%
Debt To Equity Ratio--1.1161.1160%1.013+10%0.973+15%2.462-55%
Dividend Per Share----0%0.492-100%0.275-100%0.215-100%
Eps---4.844-4.8440%1.645-394%1.076-550%1.613-400%
Free Cash Flow Per Share---2.774-2.7740%-0.075-97%1.251-322%-1.209-56%
Free Cash Flow To Equity Per Share---1.485-1.4850%2.608-157%0.429-446%1.283-216%
Gross Profit Margin--1.2321.2320%0.324+280%0.740+67%1.022+21%
Intrinsic Value_10Y_max--9.079--------
Intrinsic Value_10Y_min---28.877--------
Intrinsic Value_1Y_max--1.180--------
Intrinsic Value_1Y_min---1.651--------
Intrinsic Value_3Y_max--3.340--------
Intrinsic Value_3Y_min---6.066--------
Intrinsic Value_5Y_max--5.252--------
Intrinsic Value_5Y_min---11.659--------
Market Cap28809510576.000+37%18158305512.60018158305512.6000%33548108314.800-46%29821999440.680-39%23740927637.140-24%
Net Profit Margin---0.085-0.0850%0.029-394%0.024-449%0.030-382%
Operating Margin---0.040-0.0400%0.048-184%0.066-161%0.075-153%
Operating Ratio--1.0191.0190%0.952+7%0.923+10%0.952+7%
Pb Ratio3.856+37%2.4242.4240%4.531-47%3.911-38%2.971-18%
Pe Ratio-23.843-59%-14.987-14.9870%81.327-118%38.773-139%-23.363+56%
Price Per Share115.500+37%72.60072.6000%133.800-46%119.380-39%95.090-24%
Price To Free Cash Flow Ratio-41.643-59%-26.176-26.1760%-1794.976+6757%-335.667+1182%-283.257+982%
Price To Total Gains Ratio272.414+37%171.231171.2310%-121.526+171%1057.150-84%664.631-74%
Quick Ratio--0.7320.7320%0.762-4%0.861-15%0.776-6%
Return On Assets---0.079-0.0790%0.028-379%0.020-501%0.020-495%
Return On Equity---0.173-0.1730%0.059-393%0.036-582%-0.127-27%
Total Gains Per Share--0.4240.4240%-1.101+360%0.777-45%2.812-85%
Usd Book Value--89902812.00089902812.0000%88849560.000+1%91208618.400-1%80130505.200+12%
Usd Book Value Change Per Share--0.0050.0050%-0.019+476%0.006-16%0.031-84%
Usd Book Value Per Share--0.3590.3590%0.354+1%0.365-2%0.321+12%
Usd Dividend Per Share----0%0.006-100%0.003-100%0.003-100%
Usd Eps---0.058-0.0580%0.020-394%0.013-550%0.019-400%
Usd Free Cash Flow---8324520.000-8324520.0000%-224280.000-97%3740904.000-323%-3622584.000-56%
Usd Free Cash Flow Per Share---0.033-0.0330%-0.001-97%0.015-322%-0.015-56%
Usd Free Cash Flow To Equity Per Share---0.018-0.0180%0.031-157%0.005-446%0.015-216%
Usd Market Cap345714126.912+37%217899666.151217899666.1510%402577299.778-46%357863993.288-39%284891131.646-24%
Usd Price Per Share1.386+37%0.8710.8710%1.606-46%1.433-39%1.141-24%
Usd Profit---14539188.000-14539188.0000%4914600.000-396%3211250.400-553%4777885.200-404%
Usd Revenue--170509080.000170509080.0000%169220640.000+1%152739792.000+12%115737624.000+47%
Usd Total Gains Per Share--0.0050.0050%-0.013+360%0.009-45%0.034-85%
 EOD+6 -2MRQTTM+0 -0YOY+13 -235Y+6 -3010Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Sequent Scientific Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-23.843
Price to Book Ratio (EOD)Between0-13.856
Net Profit Margin (MRQ)Greater than0-0.085
Operating Margin (MRQ)Greater than0-0.040
Quick Ratio (MRQ)Greater than10.732
Current Ratio (MRQ)Greater than11.501
Debt to Asset Ratio (MRQ)Less than10.510
Debt to Equity Ratio (MRQ)Less than11.116
Return on Equity (MRQ)Greater than0.15-0.173
Return on Assets (MRQ)Greater than0.05-0.079
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Sequent Scientific Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.338
Ma 20Greater thanMa 50121.208
Ma 50Greater thanMa 100131.352
Ma 100Greater thanMa 200124.719
OpenGreater thanClose119.950
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Income before Tax  588,840351,910940,750425,5401,366,290-832,430533,860-1,910,450-1,376,590
Net Income  486,600212,450699,050255,370954,420-544,870409,550-1,621,149-1,211,599
EBIT  873,240405,3601,278,600420,1901,698,790-1,027,570671,220-1,238,900-567,680
EBITDA  1,292,440492,3801,784,820419,9502,204,770-1,022,7001,182,070-1,192,820-10,750
Operating Income  1,062,590189,7001,252,290435,2801,687,570-1,107,950579,620-733,080-153,460
Tax Provision  20,070100,220120,290201,480321,770-238,51083,260-240,071-156,811
Income Tax Expense  20,070100,220120,290201,480321,770-238,51083,260-240,071-156,811
Net Income from Continuing Operations  568,770251,690820,460224,0601,044,520-593,920450,600-1,670,379-1,219,779
Net Income Applicable to Common Shares  486,600212,450699,050255,370954,420-541,910412,510-1,624,109-1,211,599



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets15,291,230
Total Liabilities7,799,329
Total Stockholder Equity6,987,781
 As reported
Total Liabilities 7,799,329
Total Stockholder Equity+ 6,987,781
Total Assets = 15,291,230

Assets

Total Assets15,291,230
Total Current Assets7,898,860
Long-term Assets7,392,370
Total Current Assets
Cash And Cash Equivalents 415,740
Short-term Investments 13,080
Net Receivables 3,409,620
Inventory 3,460,890
Other Current Assets 459,750
Total Current Assets  (as reported)7,898,860
Total Current Assets  (calculated)7,759,080
+/- 139,780
Long-term Assets
Property Plant Equipment 3,521,280
Goodwill 2,400,420
Intangible Assets 684,230
Other Assets 502,900
Long-term Assets  (as reported)7,392,370
Long-term Assets  (calculated)7,108,830
+/- 283,540

Liabilities & Shareholders' Equity

Total Current Liabilities5,260,659
Long-term Liabilities2,538,670
Total Stockholder Equity6,987,781
Total Current Liabilities
Short-term Debt 2,238,250
Short Long Term Debt 2,150,980
Accounts payable 2,443,400
Other Current Liabilities 240,569
Total Current Liabilities  (as reported)5,260,659
Total Current Liabilities  (calculated)7,073,199
+/- 1,812,540
Long-term Liabilities
Long term Debt Total 2,197,700
Capital Lease Obligations 456,970
Long-term Liabilities  (as reported)2,538,670
Long-term Liabilities  (calculated)2,654,670
+/- 116,000
Total Stockholder Equity
Common Stock498,860
Retained Earnings 996,850
Accumulated Other Comprehensive Income -3,453,460
Capital Surplus 9,003,240
Total Stockholder Equity (as reported)6,987,781
Total Stockholder Equity (calculated)7,045,490
+/- 57,709
Other
Capital Stock498,860
Cash and Short Term Investments 428,820
Common Stock Shares Outstanding 250,114
Current Deferred Revenue338,440
Liabilities and Stockholders Equity 15,291,230
Net Debt 4,020,210
Net Invested Capital 10,966,761
Net Tangible Assets 3,903,130
Net Working Capital 2,638,201
Property Plant and Equipment Gross 3,521,280
Short Long Term Debt Total 4,435,950



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
498,251
1,003,342
2,555,120
3,819,730
4,498,290
5,473,540
5,862,450
6,227,140
9,076,950
14,007,140
19,046,140
13,427,620
13,878,770
15,183,020
13,925,590
14,414,950
15,291,230
15,291,23014,414,95013,925,59015,183,02013,878,77013,427,62019,046,14014,007,1409,076,9506,227,1405,862,4505,473,5404,498,2903,819,7302,555,1201,003,342498,251
   > Total Current Assets 
316,350
531,947
1,168,180
1,728,460
2,031,810
2,066,580
2,279,370
2,628,400
3,096,970
4,690,680
7,277,370
5,380,150
5,999,870
7,041,370
7,135,850
7,867,010
7,898,860
7,898,8607,867,0107,135,8507,041,3705,999,8705,380,1507,277,3704,690,6803,096,9702,628,4002,279,3702,066,5802,031,8101,728,4601,168,180531,947316,350
       Cash And Cash Equivalents 
62,642
41,305
41,030
140,680
101,960
358,790
329,910
362,130
384,570
242,500
474,040
395,440
677,890
680,960
537,440
574,960
415,740
415,740574,960537,440680,960677,890395,440474,040242,500384,570362,130329,910358,790101,960140,68041,03041,30562,642
       Short-term Investments 
0
0
0
0
0
2,770
1,770
770
5,810
632,660
732,120
202,490
4,700
401,790
59,590
16,250
13,080
13,08016,25059,590401,7904,700202,490732,120632,6605,8107701,7702,77000000
       Net Receivables 
0
0
0
0
0
0
0
875,560
1,172,360
1,923,860
2,643,520
2,719,410
3,308,330
3,187,640
3,461,370
3,292,410
3,409,620
3,409,6203,292,4103,461,3703,187,6403,308,3302,719,4102,643,5201,923,8601,172,360875,5600000000
       Inventory 
52,088
159,516
319,840
563,130
655,470
682,400
856,210
1,013,960
943,600
1,350,760
1,608,070
1,585,740
2,001,030
2,194,170
2,643,570
3,479,740
3,460,890
3,460,8903,479,7402,643,5702,194,1702,001,0301,585,7401,608,0701,350,760943,6001,013,960856,210682,400655,470563,130319,840159,51652,088
       Other Current Assets 
201,621
331,125
807,310
1,024,650
1,274,380
1,022,620
1,091,480
1,251,540
1,762,990
2,464,760
4,463,140
3,196,480
7,920
13,580
4,390
5,990
459,750
459,7505,9904,39013,5807,9203,196,4804,463,1402,464,7601,762,9901,251,5401,091,4801,022,6201,274,3801,024,650807,310331,125201,621
   > Long-term Assets 
181,900
471,395
1,386,940
2,091,270
2,466,480
3,406,960
3,583,080
3,598,740
5,979,980
9,316,460
11,768,770
8,047,470
7,878,900
8,141,650
6,789,740
6,547,940
7,392,370
7,392,3706,547,9406,789,7408,141,6507,878,9008,047,47011,768,7709,316,4605,979,9803,598,7403,583,0803,406,9602,466,4802,091,2701,386,940471,395181,900
       Property Plant Equipment 
197,341
459,871
1,129,910
1,567,340
2,368,210
2,460,070
2,701,110
2,558,950
4,269,310
4,749,880
4,011,230
2,269,200
2,442,300
3,559,530
3,478,566
3,253,430
3,521,280
3,521,2803,253,4303,478,5663,559,5302,442,3002,269,2004,011,2304,749,8804,269,3102,558,9502,701,1102,460,0702,368,2101,567,3401,129,910459,871197,341
       Goodwill 
0
0
103,090
518,460
94,530
94,530
0
94,530
710,650
1,297,870
2,242,370
2,021,930
2,209,720
2,379,740
1,742,010
1,853,080
2,400,420
2,400,4201,853,0801,742,0102,379,7402,209,7202,021,9302,242,3701,297,870710,65094,530094,53094,530518,460103,09000
       Long Term Investments 
0
0
0
0
0
0
0
360
580,370
3,605,790
3,639,740
2,217,330
1,796,500
0
0
0
0
00001,796,5002,217,3303,639,7403,605,790580,3703600000000
       Intangible Assets 
0
0
0
0
0
383,760
0
152,840
154,910
509,410
915,160
648,970
555,540
517,040
443,910
559,460
684,230
684,230559,460443,910517,040555,540648,970915,160509,410154,910152,8400383,76000000
       Long-term Assets Other 
-15,440
11,524
153,940
5,470
3,740
471,010
867,310
1,040,200
1,136,110
4,033,110
4,795,430
880,620
736,980
140,060
150,794
222,080
332,770
332,770222,080150,794140,060736,980880,6204,795,4304,033,1101,136,1101,040,200867,310471,0103,7405,470153,94011,524-15,440
> Total Liabilities 
149,010
429,632
2,149,920
2,701,920
3,267,710
4,193,370
4,866,620
5,614,080
6,694,920
5,016,110
9,106,050
6,582,000
6,409,340
7,308,050
6,162,430
7,010,820
7,799,329
7,799,3297,010,8206,162,4307,308,0506,409,3406,582,0009,106,0505,016,1106,694,9205,614,0804,866,6204,193,3703,267,7102,701,9202,149,920429,632149,010
   > Total Current Liabilities 
105,202
154,144
951,170
846,640
1,236,790
3,036,060
3,423,080
4,021,770
4,076,660
2,738,290
6,635,490
4,309,310
4,333,260
4,695,990
4,609,040
5,121,210
5,260,659
5,260,6595,121,2104,609,0404,695,9904,333,2604,309,3106,635,4902,738,2904,076,6604,021,7703,423,0803,036,0601,236,790846,640951,170154,144105,202
       Short-term Debt 
0
0
0
0
0
0
1,517,600
2,266,000
2,043,060
560,380
2,507,250
2,010,610
1,702,580
1,878,820
1,369,750
2,005,930
2,238,250
2,238,2502,005,9301,369,7501,878,8201,702,5802,010,6102,507,250560,3802,043,0602,266,0001,517,600000000
       Short Long Term Debt 
0
0
0
0
0
0
0
4,181,050
187,900
448,960
2,507,250
2,010,320
1,687,030
1,805,890
1,029,050
1,924,360
2,150,980
2,150,9801,924,3601,029,0501,805,8901,687,0302,010,3202,507,250448,960187,9004,181,0500000000
       Accounts payable 
0
0
0
0
0
0
1,507,690
1,145,870
909,350
1,439,350
2,030,410
1,604,920
2,093,500
2,203,800
2,295,640
2,580,450
2,443,400
2,443,4002,580,4502,295,6402,203,8002,093,5001,604,9202,030,4101,439,350909,3501,145,8701,507,690000000
       Other Current Liabilities 
105,202
154,144
951,170
846,640
1,236,790
3,036,060
397,790
609,900
1,124,250
2,177,910
2,045,890
604,060
469,510
103,210
131,150
137,660
240,569
240,569137,660131,150103,210469,510604,0602,045,8902,177,9101,124,250609,900397,7903,036,0601,236,790846,640951,170154,144105,202
   > Long-term Liabilities 
43,807
275,487
1,198,750
1,855,280
2,030,920
1,157,310
1,443,540
1,592,310
2,618,260
2,277,820
2,470,560
2,272,690
2,076,080
2,612,060
1,553,390
1,889,610
2,538,670
2,538,6701,889,6101,553,3902,612,0602,076,0802,272,6902,470,5602,277,8202,618,2601,592,3101,443,5401,157,3102,030,9201,855,2801,198,750275,48743,807
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
2,113,200
1,651,790
1,098,250
1,523,180
2,034,880
1,391,030
1,224,550
2,197,700
2,197,7001,224,5501,391,0302,034,8801,523,1801,098,2501,651,7902,113,200000000000
       Other Liabilities 
0
0
0
0
0
0
0
81,470
132,220
784,680
807,910
1,174,440
543,360
326,180
162,360
246,540
0
0246,540162,360326,180543,3601,174,440807,910784,680132,22081,4700000000
> Total Stockholder Equity
349,241
573,710
200,540
1,086,720
1,222,960
1,225,270
950,030
567,260
912,740
8,734,110
9,767,910
6,475,770
7,066,920
7,427,600
7,276,510
6,924,070
6,987,781
6,987,7816,924,0707,276,5107,427,6007,066,9206,475,7709,767,9108,734,110912,740567,260950,0301,225,2701,222,9601,086,720200,540573,710349,241
   Common Stock
75,000
110,852
110,850
212,350
212,350
213,400
234,400
267,400
304,850
476,470
487,470
487,470
493,740
496,740
496,740
496,740
498,860
498,860496,740496,740496,740493,740487,470487,470476,470304,850267,400234,400213,400212,350212,350110,850110,85275,000
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income -3,453,460-3,146,380-2,457,320-1,353,750-991,020-740,120-793,820-1,455,520-963,850-1,103,310-880,770-665,980-535,010-411,100-185,840-76,709-47,233
   Capital Surplus 
0
0
0
0
0
0
0
0
0
9,591,720
10,130,650
8,345,140
8,490,360
8,603,820
8,726,860
8,742,550
9,003,240
9,003,2408,742,5508,726,8608,603,8208,490,3608,345,14010,130,6509,591,720000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
321,474
539,567
275,530
1,285,470
1,545,620
1,677,850
1,888,020
2,796,780
3,053,950
11,414,230
10,074,260
8,617,740
8,966,840
6,938,470
6,180,110
5,538,460
5,492,071
5,492,0715,538,4606,180,1106,938,4708,966,8408,617,74010,074,26011,414,2303,053,9502,796,7801,888,0201,677,8501,545,6201,285,470275,530539,567321,474



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue14,209,090
Cost of Revenue-8,337,670
Gross Profit5,871,4205,871,420
 
Operating Income (+$)
Gross Profit5,871,420
Operating Expense-6,140,950
Operating Income-153,460-269,530
 
Operating Expense (+$)
Research Development0
Selling General Administrative540,260
Selling And Marketing Expenses281,330
Operating Expense6,140,950821,590
 
Net Interest Income (+$)
Interest Income513,120
Interest Expense-355,170
Other Finance Cost-513,120
Net Interest Income-355,170
 
Pretax Income (+$)
Operating Income-153,460
Net Interest Income-355,170
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,376,5901,069,660
EBIT - interestExpense = -922,850
-1,368,410
-856,429
Interest Expense355,170
Earnings Before Interest and Taxes (EBIT)-567,680-1,021,420
Earnings Before Interest and Taxes (EBITDA)-10,750
 
After tax Income (+$)
Income Before Tax-1,376,590
Tax Provision--156,811
Net Income From Continuing Ops-1,219,779-1,219,779
Net Income-1,211,599
Net Income Applicable To Common Shares-1,211,599
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,478,620
Total Other Income/Expenses Net-1,223,120355,170
 

Technical Analysis of Sequent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sequent. The general trend of Sequent is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sequent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sequent Scientific Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 121.10 < 155.50 < 156.00.

The bearish price targets are: 113.80 > 113.35 > 108.10.

Tweet this
Sequent Scientific Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sequent Scientific Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sequent Scientific Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sequent Scientific Limited. The current macd is -4.88793574.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sequent price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sequent. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sequent price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sequent Scientific Limited Daily Moving Average Convergence/Divergence (MACD) ChartSequent Scientific Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sequent Scientific Limited. The current adx is 32.44.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sequent shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Sequent Scientific Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sequent Scientific Limited. The current sar is 124.45.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sequent Scientific Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sequent Scientific Limited. The current rsi is 41.34. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Sequent Scientific Limited Daily Relative Strength Index (RSI) ChartSequent Scientific Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sequent Scientific Limited. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sequent price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sequent Scientific Limited Daily Stochastic Oscillator ChartSequent Scientific Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sequent Scientific Limited. The current cci is -53.92699716.

Sequent Scientific Limited Daily Commodity Channel Index (CCI) ChartSequent Scientific Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sequent Scientific Limited. The current cmo is -17.05999927.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sequent Scientific Limited Daily Chande Momentum Oscillator (CMO) ChartSequent Scientific Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sequent Scientific Limited. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sequent is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sequent Scientific Limited Daily Williams %R ChartSequent Scientific Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sequent Scientific Limited.

Sequent Scientific Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sequent Scientific Limited. The current atr is 7.27629792.

Sequent Scientific Limited Daily Average True Range (ATR) ChartSequent Scientific Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sequent Scientific Limited. The current obv is 394,942,723.

Sequent Scientific Limited Daily On-Balance Volume (OBV) ChartSequent Scientific Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sequent Scientific Limited. The current mfi is 56.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sequent Scientific Limited Daily Money Flow Index (MFI) ChartSequent Scientific Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sequent Scientific Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Sequent Scientific Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sequent Scientific Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.338
Ma 20Greater thanMa 50121.208
Ma 50Greater thanMa 100131.352
Ma 100Greater thanMa 200124.719
OpenGreater thanClose119.950
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sequent with someone you think should read this too:
  • Are you bullish or bearish on Sequent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sequent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sequent Scientific Limited

I send you an email if I find something interesting about Sequent Scientific Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Sequent Scientific Limited.

Receive notifications about Sequent Scientific Limited in your mailbox!